Status:
UNKNOWN
Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Head and Neck Neoplasms
Chemoradiotherapy
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
The aim of the study is to evaluate the effects of Herbal gargle on chemoradiotherapy-induced stomatitis in head \& neck cancer patients.
Detailed Description
Head and neck cancer accounts for about 5% of all cancers worldwide with the age-standardized incidence rate (ASIR) of HNC increased by 5.4% per year among males and 3.1% among females in Taiwan. Conc...
Eligibility Criteria
Inclusion
- Willing to join the trial project and sign the informed consent form.
- Age more than 20 years-old.
- Pathology proved to be head and neck cancers.
- Head and neck cancer patients under radiotherapy or concurrent chemoradiotherapy.
- Expected life expectancy more than 3 months.
- Subjects with clear consciousness and can be assessed cooperatively.
- Subjects are suitable to use Herbal gargle evaluated by Traditional Chinese medicine physicians.
Exclusion
- Subjects can not sing the informed consent form.
- Systemic infection.
- Heart, liver and kidney insufficiency
- Allergy history of Traditional Chinese medicine
- Unclear conscious to use Herbal gargle.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05341206
Start Date
April 15 2022
End Date
December 31 2025
Last Update
April 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keelung Chang Gung Memorial Hospital
Keelung, Keelung, Taiwan, Taiwan, 20401